D. E. Shaw & Co., Inc. - IMMUNE DESIGN CORP ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$1,503,000
+462.9%
257,007
+25.3%
0.00%
Q4 2018$267,000
-24.1%
205,148
+101.2%
0.00%
Q3 2018$352,000
+324.1%
101,947
+461.1%
0.00%
Q2 2018$83,000
+36.1%
18,170
-1.6%
0.00%
Q1 2018$61,000
-83.6%
18,458
-80.6%
0.00%
-100.0%
Q4 2017$371,000
+256.7%
95,017
+848.0%
0.00%
Q3 2017$104,000
-46.9%
10,023
-50.2%
0.00%
Q2 2017$196,000
-16.9%
20,122
-41.9%
0.00%
Q1 2017$236,000
-12.6%
34,662
-29.5%
0.00%
Q4 2016$270,000
+26.2%
49,180
+361.4%
0.00%
Q4 2015$214,00010,6590.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Svennilson Peter 6,642,942$8,636,0007.61%
Versant Venture Management, LLC 2,208,210$2,870,673,0001.42%
BVF INC/IL 5,185,383$6,741,0000.88%
EcoR1 Capital, LLC 5,603,191$7,284,0000.73%
Abingworth LLP 352,300$458,0000.42%
Bain Capital Public Equity Management, LLC 892,061$1,160,0000.11%
ALGERT GLOBAL LLC 92,591$120,0000.03%
GSA CAPITAL PARTNERS LLP 41,068$53,0000.01%
OXFORD ASSET MANAGEMENT LLP 136,468$177,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 27,122$35,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders